TSX:BHC (Bausch Health Companies Inc.)

About BHC

Bausch Health Companies Inc. is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries. Five pillars or guiding principles represent the foundation on which we are realizing our mission as an organization: People Quality Health Care Outcomes Customer Focus Innovation and Efficiency.
  • Bausch Health Companies Inc. (TSX: BHC) Latest News

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. Takes Another Step Closer to Death

    After unloading another business, Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is another step closer to being crippled by the interest expenses.

    Read more »

    The Motley Fool
    Investing

    Get ‘Em While They’re Hot: Shares of Valeant Pharmaceuticals Intl Inc. Climb

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has continued to make headway towards its proposed $5 billion debt-repayment schedule set for February…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. May Raise Another US$2 Billion to Pay Back Debt: Time to Buy?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) made another deal. Is Valeant well positioned to meet its goal of debt repayment? Is…

    Read more »

    The Motley Fool
    Investing

    Contrarian Investors: Don’t Expect a Sudden Rebound in Valeant Pharmaceuticals Intl Inc.

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) appears to be getting cheaper by the day. Is it finally time to initiate a…

    Read more »

    The Motley Fool
    Investing

    Don’t Miss Out on This Bargain Stock Before it’s Too Late

    While Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) doesn't currently pay a dividend, the company has a very healthy cash flow stream,…

    Read more »

    hospital beds
    Dividend Stocks

    Invest in the Healthcare Industry to Take Advantage of Demographic Trends

    The aging population means that Chartwell Retirement Residences (TSX:CSH.UN) and Extendicare Inc. (TSX:EXE) are in the right business for the…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: Is the Turnaround Working?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) continues to take the right steps, but a turnaround will take time.

    Read more »

    The Motley Fool
    Investing

    An Update on the Solvency Issues at Valeant Pharmaceuticals Intl Inc.

    After two very difficult years, Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is simply two years closer to bankruptcy.

    Read more »

    The Motley Fool
    Investing

    What a Return to Profits for Valeant Pharmaceuticals Intl Inc. Means

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) posted a profit for the first time since 2015 this week, but the company still…

    Read more »

    The Motley Fool
    Investing

    Was Bill Ackman Wrong to Sell His Stake in Valeant Pharmaceutical Intl Inc.?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) soared 24.1% in a single trading session following an upgraded forecast. Is it time to…

    Read more »

    The Motley Fool
    Investing

    1 Beaten-Up Stock With a Potential 50% Upside

    Here's my take on why Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is currently undervalued by approximately 50%.

    Read more »

    Investing

    What Canopy Growth Corp can Learn From Valeant Pharmaceuticals Intl Inc

    After egregious destruction of shareholder wealth, Valeant Pharmaceuticals Intl Inc (TSX:VRX)(NYSE:VRX) will hopefully be a learning opportunity for Canopy Growth…

    Read more »